Manchester Academic Health Sciences Centre, Cerebral Function Unit, Greater Manchester Neuroscience Centre, Salford Royal NHS Foundation Trust, Salford, UK.
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):172-6. doi: 10.3109/21678421.2013.765485. Epub 2013 Feb 19.
Repeat expansions in C9orf72 are a major cause of frontotemporal dementia with amyotrophic lateral sclerosis (FTD-ALS). Not all FTD-ALS patients show expansions. The study examined whether there are clinical differences between FTD-ALS patients with and without expansions in C9orf72. We examined case notes from consecutive FTD-ALS patients, screened for C9orf72 expansions, and documented demographic, neurological, behavioural and cognitive characteristics. Sixty patients met the selection criteria, of whom 11 showed expanded repeats (C9-positive) and 49 did not (C9-negative). A strong male bias was present in the C9-negative group only. A family history of FTD or ALS was recorded in both groups, but was significantly more common in C9-positive cases. Psychotic and irrational behaviours, apathy, disinhibition and loss of empathy were significantly more common in C9-positive cases, with a trend towards more frequent bulbar signs. No differences were found in onset age, presentation (ALS or FTD first), or cognitive changes (language and executive impairments). In conclusion, FTD-ALS is not clinically uniform. Phenotypic differences exist between patients with and without C9orf72 expansions, suggesting that FTD-ALS may be underpinned by distinct neurobiological substrates. The presence of psychiatric symptoms in the context of FTD-ALS should alert clinicians to the possibility of C9orf72 expansions.
C9orf72 重复扩展是额颞叶痴呆伴运动神经元病(FTD-ALS)的主要原因。并非所有 FTD-ALS 患者都显示出扩展。本研究旨在探讨 C9orf72 扩展的 FTD-ALS 患者与无扩展的患者之间是否存在临床差异。我们检查了连续的 FTD-ALS 患者的病历,对 C9orf72 扩展进行了筛查,并记录了人口统计学、神经学、行为和认知特征。符合选择标准的 60 名患者中,有 11 名表现出扩展重复(C9 阳性),49 名未表现出扩展重复(C9 阴性)。仅在 C9 阴性组中存在强烈的男性偏倚。两组均记录了 FTD 或 ALS 的家族史,但 C9 阳性病例更为常见。C9 阳性病例中出现明显更多的精神病和非理性行为、冷漠、抑制丧失和同理心丧失,且延髓体征更为常见。在发病年龄、表现(首先出现 ALS 或 FTD)或认知变化(语言和执行功能障碍)方面未发现差异。总之,FTD-ALS 并非临床表现完全一致。C9orf72 扩展的患者与无扩展的患者之间存在表型差异,这表明 FTD-ALS 可能有不同的神经生物学基础。在 FTD-ALS 背景下出现精神症状时,临床医生应警惕 C9orf72 扩展的可能性。